Protagonist Therapeutics Inc.

NASDAQ: PTGX
Share price (1/3/25): $39.57
Market cap (1/3/25): $2.358 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Molina Arturo MD

Molina Arturo MD

Patel Dinesh V Ph D

Molina Arturo MD

News Filter

Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113) in Plaque Psoriasis, a First-In-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor

Top Line Results for JNJ-2113 Phase 3 ICONIC-LEAD and Phase 3 ICONIC-TOTAL Clinical Trials in Patients With Moderate to Severe Psoriasis Expected in Q4 2024

Change in Directors, Officers or Compensation

Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC